The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary data from an ongoing phase 1 dose-escalation study of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors.
 
Gonzalo Tapia
Employment - Icon Cancer Care
 
Joanne Lundy
Patents, Royalties, Other Intellectual Property - Patent pending for molecular diagnostic signature of pancreatic cancer. (Inst)
 
Gary Edward Richardson
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CBT Pharmaceuticals (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Fosun Pharma (Inst); Merck (Inst); Novotech (Inst); Pfizer (Inst); Roche/Genentech (Inst); Shanghai Henlius Biotech (Inst); Suzhou Alphamab (Inst); Takeda (Inst)
 
Niky Zhao
Employment - ChemoCentryx
Leadership - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Karen Ebsworth
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Huibin Yue
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
Travel, Accommodations, Expenses - ChemoCentryx
 
Shichang Miao
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
Patents, Royalties, Other Intellectual Property - ChemoCentryx
 
Emil deGoma
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
Travel, Accommodations, Expenses - ChemoCentryx
 
Rita Jain
Employment - ChemoCentryx; Immunovant; Intelia (I)
Leadership - AM Pharma; ChemoCentryx; ImmunoVant; Intellia Therapeutics (I); IQvia (I)
Stock and Other Ownership Interests - ChemoCentrx; Intellia Therapeutics (I); IQvia (I)
 
Thomas J. Schall
Employment - ChemoCentryx
Leadership - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
Travel, Accommodations, Expenses - ChemoCentryx
 
Kathleen Sullivan
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics
 
Penglie Zhang
Employment - Arcus Biosciences (I); ChemoCentryx
Stock and Other Ownership Interests - Arcus Biosciences (I); ChemoCentryx
Patents, Royalties, Other Intellectual Property - ChemoCentryx
 
Paul L. de Souza
Stock and Other Ownership Interests - Filamon Pty
Consulting or Advisory Role - Biosceptre International; Harbour BioMed